Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 4, 2008, Pages 877-879

  Serena, Carolina ^a   Rodríguez, M Mar ^a   Mariné, Marçal ^a   Pastor, F Javier ^a   Guarro, Josep ^a  

^a FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

Blastoschizomyces capitatus; Combined therapy; Echinocandins

Indexed keywords

CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUOROURACIL; MICAFUNGIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLASTOSCHIZOMYCES CAPITATUS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DILUTION; DISSEMINATED BLASTOSCHIZOMYCOSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; FUNGAL STRAIN; FUNGUS; INFECTION CONTROL; KAPLAN MEIER METHOD; MALE; MONOTHERAPY; MOUSE; MYCOSIS; NONHUMAN; SINGLE DRUG DOSE; SURVIVAL TIME; TREATMENT DURATION;

ANIMALS; ANTIFUNGAL AGENTS; BLASTOMYCOSIS; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; ECHINOCANDINS; FLUCONAZOLE; KIDNEY; LIPOPROTEINS; LIVER; MALE; MICE; MICROBIAL SENSITIVITY TESTS; SPLEEN; SURVIVAL ANALYSIS;

EID: 41149127290     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn012     Document Type: Article

References (10)

1. Girmenia C, Pagano L, Martino B et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: A retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43 1818-28.
2. Serena C, Mariné M, Marimon R et al. Effect of antifungal treatment in a murine model of blastoschizomycosis. Int J Antimicrob Agents 2007; 29: 79-83.
3. Christakis G, Perlorentzou S, Aslanidou M et al. Fatal Blastoschizomyces capitatus sepsis in a neutropenic patient with acute myeloid leukemia: First documented case from Greece. Mycoses 2005; 48: 216-20.
4. Martino R, Salavert M, Parody R et al. Blastoschizomyces capitatus infection in patients with leukemia: Report of 26 cases. Clin Infect Dis 2004; 38: 335-41.
5. Serena C, Rodríguez MM, Mariné M et al. Combined therapies in a murine model of blastoschizomycosis. Antimicrob Agents Chemother 2007; 51: 2608-10.
6. Serena C, Pastor FJ, Gilgado F et al. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother 2005; 51: 2608-10.
7. Marine M, Serena C, Pastor FJ et al. Combined antifungal therapies in a murine infection by Candida glabrata. J Antimicrob Chemother 2006; 58: 1295-8.
8. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts - Second Edition: Approved Standard M27-A2. NCCLS, Wayne, PA, USA, 2002.
9. Johnson MD, MacDougall C, Ostrosky-Zeichner L et al. Combination antifungal therapy. Antimicrob Agents Chemother 2004; 48: 693-715.
10. Graybill JR, Bocanegra R, Najvar LK et al. Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: Role of immune suppression. Antimicrob Agents Chemother 1998; 42: 2467-73.